| Schedule of Weighted Average Shares of Common Stock Outstanding |
The weighted average shares of common stock outstanding used to determine the Company’s net income (loss) per share reflects the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
(amounts in thousands, except number of shares and amount per share) |
|
June 30,
2026 |
|
|
June 30,
2025 |
|
|
June 30,
2026 |
|
|
June 30,
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
(318 |
) |
|
$ |
25,112 |
|
|
$ |
5,803 |
|
|
$ |
17,020 |
|
Net income (loss) attributable to noncontrolling interests |
|
|
(622 |
) |
|
|
13,668 |
|
|
|
1,782 |
|
|
|
9,253 |
|
Series B Preferred Stock dividends |
|
|
(946 |
) |
|
|
— |
|
|
|
(1,857 |
) |
|
|
— |
|
Income allocated to participating Series B Preferred Stock |
|
|
— |
|
|
|
— |
|
|
|
(337 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to Class A common stockholders |
|
|
(642 |
) |
|
|
11,444 |
|
|
|
1,827 |
|
|
|
7,767 |
|
Adjustment for dilutive RSUs |
|
|
— |
|
|
|
— |
|
|
|
6 |
|
|
|
— |
|
Adjustment for dilutive warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,327 |
) |
Dilutive net income (loss) attributable to Class A common stockholders |
|
$ |
(642 |
) |
|
$ |
11,444 |
|
|
$ |
1,833 |
|
|
$ |
6,440 |
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average Class A common stock outstanding – basic |
|
|
49,327,318 |
|
|
|
37,523,324 |
|
|
|
49,269,329 |
|
|
|
37,423,300 |
|
Adjustment for dilutive RSUs |
|
|
— |
|
|
|
2,570 |
|
|
|
258,547 |
|
|
|
4,334 |
|
Adjustment for dilutive warrants |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
93,475 |
|
Weighted average Class A common stock outstanding – diluted |
|
|
49,327,318 |
|
|
|
37,525,894 |
|
|
|
49,527,876 |
|
|
|
37,521,109 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per Class A common share – basic: |
|
|
(0.01 |
) |
|
|
0.30 |
|
|
|
0.04 |
|
|
|
0.21 |
|
Net income (loss) per Class A common share – diluted: |
|
|
(0.01 |
) |
|
|
0.30 |
|
|
|
0.04 |
|
|
|
0.17 |
|
|
| Securities not Included in the Computation Because the Effect Would be Anti-dilutive |
The following securities were not included in the computation because the effect would be anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Six months ended |
|
|
|
June 30,
2026 |
|
|
June 30,
2025 |
|
|
June 30,
2026 |
|
|
June 30,
2025 |
|
Class A earnout shares |
|
|
625,000 |
|
|
|
1,000,000 |
|
|
|
625,000 |
|
|
|
1,000,000 |
|
Class B earnout shares |
|
|
24,375,000 |
|
|
|
39,000,000 |
|
|
|
24,375,000 |
|
|
|
39,000,000 |
|
Series B Preferred Stock shares |
|
|
7,086,960 |
|
|
|
— |
|
|
|
7,086,960 |
|
|
|
— |
|
RSUs |
|
|
859,713 |
|
|
|
929,662 |
|
|
|
— |
|
|
|
929,662 |
|
Class A shares subject to forfeiture under the deferred settlement agreement |
|
|
360,000 |
|
|
|
— |
|
|
|
360,000 |
|
|
|
— |
|
With respect to unvested Class A earnout shares, 375,000 are subject to forfeiture under the deferred settlement agreement.
|